Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Atsenbo (Suzhou) Pharmaceutical Technology Co. Ltd. is currently handling 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are concentrated in 1 distinct art unit but are being reviewed by 2 distinct examiners. This concentration in 1 art unit suggests that the company's innovations are technically similar, even though they are being evaluated by different individuals.
BOECKER, JOSEPH D is the busiest examiner, with 1 pending office action. Because there are 2 examiners for the 2 pending office actions, the workload is split evenly, with each examiner managing a single matter. For the practitioner, this means that while the technical standards of the art unit will be consistent, the prosecution strategy must be tailored to the individual preferences of BOECKER, JOSEPH D and the other assigned examiner. This split workload requires maintaining two separate dialogues within the same 1 art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BOECKER, JOSEPH D | 1 | 83.7% | +22.9% |
| VO, TU A | 1 | 61.0% | +58.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18838066 | TRIGGER ASSEMBLY FOR ATOMIZER AND ATOMIZER | BOECKER, JOSEPH D | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18838066 | TRIGGER ASSEMBLY FOR ATOMIZER AND ATOMIZER | BOECKER, JOSEPH D | — |
| 18729455 | TRIGGER ASSEMBLY FOR ATOMIZER, AND ATOMIZER | VO, TU A | — |
| Art Unit | Apps |
|---|---|
| 3785 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18838066 | TRIGGER ASSEMBLY FOR ATOMIZER AND ATOMIZER | BOECKER, JOSEPH D | 3785 | §112 | Non-Final OA | — | Pending | Aug 13, 2024 |
| 18729455 | TRIGGER ASSEMBLY FOR ATOMIZER, AND ATOMIZER | VO, TU A | 3785 | §102§112 | Non-Final OA | — | Pending | Jul 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAtsenbo (Suzhou) Pharmaceutical Technology Co. Ltd. has 2 pending office actions as of October 2026, spread across 1 art units and 2 examiners.
Joseph D Boecker has the most, with 1 of Atsenbo (Suzhou) Pharmaceutical Technology Co. Ltd.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
